ACE2 Receptor-Targeted Inhaled Nanoemulsions Inhibit SARS-CoV-2 and Attenuate Inflammatory Responses.
Wang H, Luo S, Xie M, Chen Z, Zhang Y, Xie Z, Zhang Y, Zhang Y, Yang L, Wu F, Chen X, Du G, Zhao J, Sun X.
Wang H, et al. Among authors: chen z, chen x.
Adv Mater. 2024 Apr;36(14):e2311537. doi: 10.1002/adma.202311537. Epub 2024 Jan 4.
Adv Mater. 2024.
PMID: 38174591